Metabolite information |
|
HMDB ID | HMDB0000991 |
Synonyms |
(+-)-2-Aminooctanoate(+-)-2-Aminooctanoic acid(+/-)-2-amino-octanoate(+/-)-2-amino-octanoic acid(+/-)-2-aminooctanoate(+/-)-2-aminooctanoic acid2-Aminocaprylate2-Aminocaprylic acid2-Aminooctanoate2-Aminooctanoic acid2-amino-DL-Caprylate2-amino-DL-Caprylic acid2-amino-DL-Octanoate2-amino-DL-Octanoic acidD,L-2-AminooctanoateD,L-2-Aminooctanoic acidDL-2-AminocaprylateDL-2-Aminocaprylic acidDL-2-AminooctanoateDL-a-AminocaprylateDL-a-Aminocaprylic acidDL-a-amino-N-CaprylateDL-a-amino-N-Caprylic acidDL-alpha-AminocaprylateDL-alpha-Aminocaprylic acidDL-alpha-amino-N-CaprylateDL-alpha-amino-N-Caprylic acidDL-α-amino-N-caprylateDL-α-amino-N-caprylic acidDL-α-aminocaprylateDL-α-aminocaprylic acidNSC 20147a-Aminocaprylatea-Aminocaprylic acida-Aminooctanoatea-Aminooctanoic acidalpha-Aminocaprylatealpha-Aminocaprylic acidalpha-Aminooctanoatealpha-Aminooctanoic acidα-aminocaprylateα-aminocaprylic acidα-aminooctanoateα-aminooctanoic acid |
Chemical formula | C8H17NO2 |
IUPAC name | 2-aminooctanoic acid |
CAS registry number | 644-90-6 |
Monoisotopic molecular weight | 159.125928793 |
Chemical taxonomy |
|
Super class | Organic acids and derivatives |
Class | Carboxylic acids and derivatives |
Sub class | Amino acids, peptides, and analogues |
Biological properties |
|
Pathways (Pathway Details in HMDB) |
|
Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
Mazzone et al. 2016 | US | serum | – | adenocarcinoma, squamous cell carcinoma | I, II, III | 94 | 55.3%, 44.7% | 68.7 | – | at-risk controls | 190 | 50.5%, 49.5% | 66.2 | – |
Moreno et al. 2018 | Spain | tissue | therapy, diagnosis | squamous cell carcinoma | I, II, III | 35 | 35, 0 | 68.71 ± 7.46 | – | tumor vs. adjacent normal tissue | 35 | 35, 0 | 68.71 ± 7.46 | – |
Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
Mazzone et al. 2016 | LC | ESI | positive | linear ion-trap | MS/MS |
Moreno et al. 2018 | LC, GC | ESI, EI | both | LC: linear ion-trap, GC: single-quadrupole | LC: MS/MS |
Reference | Data processing software | Database search |
Mazzone et al. 2016 | Metabolon LIMS system | Metabolon LIMS system |
Moreno et al. 2018 | – | KEGG, HMDB |
Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
Mazzone et al. 2016 | two- sample independent t test | 1.172518± 0.7960609 | 1.202206± 0.7188863 | 0.98 | 0.75 | 0.73 | – |
Moreno et al. 2018 | paired two-sample t-test, PLS-DA | – | – | 1.61 | 1.01e-03 | 1.62e-03 | – |
Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
Mazzone et al. 2016 | – | – | – | – | – | – |
Moreno et al. 2018 | – | – | – | – | – | – |